Checkpoint checkmate: Microbiota modulation of cancer immunotherapy

TY - JOUR

T1 - Checkpoint checkmate

T2 - Microbiota modulation of cancer immunotherapy

AU - Keen, Eric C.

AU - Crofts, Terence S.

AU - Dantas, Gautam

N1 - Funding Information: Employment or Leadership: None declared. Consultant or Advisory Role: None declared. Stock Ownership: None declared. Honoraria: None declared. Research Funding: E.C. Keen, National Science Foundation Graduate Research Fellowship (DGE-1143945); T.S. Crofts, National Institute of Child Health and Development training grant through award number T32 HD049305 (Kelle H. Moley, Principal Investigator) and a National Institute of Diabetes and Digestive and Kidney Diseases training grant through award number T32 DK077653 (Phillip I. Tarr, Principal Investigator); G. Dantas, awards through the Edward Mallinckrodt Jr. Foundation (Scholar Award), the National Institute of Allergy and Infectious Diseases (NIAID: https://www.niaid.nih.gov/), and the Eunice Kennedy Shriver National Institute of Child Health & Human Development (https://www.nichd.nih.gov/) of the National Institutes of Health (NIH) under award numbers R01AI123394 and R01HD092414, respectively. Expert Testimony: None declared. Patents: None declared.

PY - 2018/9

Y1 - 2018/9

UR - https://www.scopus.com/pages/publications/85052452862

U2 - 10.1373/clinchem.2017.286229

DO - 10.1373/clinchem.2017.286229

M3 - Review article

C2 - 29691222

AN - SCOPUS:85052452862

SN - 0009-9147

VL - 64

SP - 1280

EP - 1283

JO - Clinical chemistry

JF - Clinical chemistry

IS - 9

ER -